Skip to main content

Humanin vs Glutathione (GSH)

Both Humanin and Glutathione (GSH) are used for longevity. Here's how their evidence, dosing, and regulatory status actually compare.

Humanin

Evidence B

Humanin (HN)

A 24-amino-acid mitochondrial-derived peptide with cytoprotective effects across Alzheimer's, diabetes, and atherosclerosis preclinical models. Endogenous levels decline sharply with age.

View full Humanin profile →

Glutathione (GSH)

Evidence B

Reduced L-Glutathione

Technically a tripeptide (γ-glutamyl-cysteinyl-glycine) and the body's primary antioxidant. Often grouped with peptide therapy in IV/compounded form for liver support and oxidative stress.

View full Glutathione (GSH) profile →

Side-by-Side

AttributeHumaninGlutathione (GSH)
Evidence GradeBB
FDA StatusNot FDA-approved — mitochondrial-derived peptide research compoundNot FDA-approved as therapeutic — sold as supplement; intravenous use compounded
Typical DoseResearch range: 0.5–1 mg subcutaneous (rare clinical use)200–600 mg sublingual / 600–2400 mg IV (compounded)
Clinics Indexed5312
Categoriesmitochondrial, longevity, neuroprotectionantioxidant, longevity

Key reported benefits — Humanin

  • Cytoprotection
  • Anti-amyloid effects
  • Insulin sensitization

Key reported benefits — Glutathione (GSH)

  • Master antioxidant
  • Liver detoxification support
  • Oxidative stress reduction

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons